Average Co-Inventor Count = 1.00
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mederis Diabetes, LLC (5 from 5 patents)
2. Transition Therapeutics, Inc. (2 from 7 patents)
3. Spitfire Pharma, Inc. (2 from 3 patents)
4. Eumederis Pharmaceuticals, Inc. (2 from 2 patents)
5. Altimmune, Inc. (1 from 12 patents)
6. Forbes Medi-tech (research), Inc. (1 from 1 patent)
13 patents:
1. 12257229 - Peptide pharmaceuticals for treatment of NASH and other disorders
2. 11911447 - Peptide pharmaceuticals for insulin resistance
3. 11541028 - Peptide pharmaceuticals for treatment of NASH and other disorders
4. 11065304 - Peptide pharmaceuticals for insulin resistance
5. 10577405 - Peptide pharmaceuticals for insulin resistance
6. 10471127 - Peptide pharmaceuticals for insulin resistance
7. 10420844 - Peptide pharmaceuticals
8. 10010617 - Peptide pharmaceuticals
9. 10005817 - Peptide pharmaceuticals
10. 9856306 - Peptide pharmaceuticals for insulin resistance
11. 7595294 - Vasoactive intestinal polypeptide pharmaceuticals
12. 7566691 - Vasoactive intestinal polypeptide pharmaceuticals
13. 7189748 - Compounds and methods for treating insulin resistance and cardiomyopathy